Navigation Links
Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
Date:2/4/2013

MADISON, Wis., Feb. 4, 2013 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that Harry S. Palmin, President and CEO of Novelos, will present a corporate update at the 15th Annual BIO CEO & Investor Conference on Monday, February 11, 2013.  Mr. Palmin is scheduled to present at 2pm ET in the Duke of Windsor Suite on the 4th floor.  The event will be held February 11-12 at The Waldorf Astoria in New York City.

A live webcast of the Novelos presentation may be accessed via www.novelos.com 
The webcast will be archived for 90 days following the presentation.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies.  Information about the conference is available at http://www.bio.org/events/conferences/bio-ceo-investor-conference

About Novelos Therapeutics, Inc.
We are a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer.  Our cancer-targeted compounds are selectively taken up and retained in cancer cells, including cancer stem cells, versus normal cells.  Thus, our therapeutic compounds appear to directly kill cancer cells while minimizing harm to normal cells.  This offers the potential for a paradigm shift in cancer therapy by providing efficacy versus all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse.  I-124-CLR1404 (LIGHT) is a small-molecule, broad-spectrum, cancer-targeted PET imaging agent.  We believe LIGHT has first-in-class potential and Phase 1-2 clinical trials are ongoing across 11 solid tumo
'/>"/>

SOURCE Novelos Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Novelos Therapeutics Prices $5.4 Million Public Offering
4. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
5. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
6. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
7. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
9. Novelos Therapeutics Closes $2 Million Private Placement
10. Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29
11. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , LONDON , ... May 20, 2013 Arthroscopy ... Osteoarthritis and Preference for Minimally Invasive Procedures to Drive ... and market trends for the six arthroscopy device market ... arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy visualization ...
(Date:5/20/2013)... 20, 2013  Medicare Part D seniors in ... citing lower costs, convenient access to pharmacies and ... Hart Research Associates released today by the Pharmaceutical ... Part D seniors (9.5 million) are currently enrolled ... like the lower costs, pharmacy choices, and overall ...
(Date:5/19/2013)... May 20, 2013  Whole-cell pertussis vaccines were more ... during a large recent outbreak, according to a new ... pertussis vaccines, also called DTwP, were available from the ... that ultimately led to the development of acellular pertussis ... 1990s, the United States had ...
Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... March 31, 2011, and provided a business update.  The ... and 2010, as reported in accordance with accounting principles ... and $13.4 million, respectively.  At March 31, 2011, Alexza ...
... ALISO VIEJO, Calif., May 9, 2011 Avanir Pharmaceuticals, Inc. ... the three and six months ended March 31, 2011. ... $1.4 million (deferred royalty revenue and recognized NUEDEXTA® revenue) Gross ... $3.1 million Quarter end cash, cash equivalents, and investments of ...
Cached Medicine Technology:Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 2Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 3Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 4Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 5Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 6Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 7Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 8Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 9Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results 2Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results 3Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results 4Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results 5Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results 6Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results 7Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results 8
(Date:5/20/2013)... 20, 2013 When people have ... always to become a celebrity. New Jersey governor ... ABC News report (“Chris Christie Says Lap Band ... that the surgery was not done so that ... celebrity status as a former lap band patient. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 The new ... lives and health of all Americans. However, not all ... immediate impact as some might take up to 2014 ... Human Services (HHS), some states are currently moving forward ... Insurance Marketplaces, such as: Iowa, Michigan, New Hampshire, and ...
(Date:5/20/2013)... Fountain Valley, CA (PRWEB) May 20, 2013 ... few dental professionals certified and trained to use the ... surgery designed to treat patients with gum disease. ... already lost teeth due to gum disease restore the ... disease begins with the buildup of plaque and tartar ...
(Date:5/20/2013)... Daily Gossip, online magazine about lifestyle, health and sports ... that can help them overcome one of the most spread ... Natural Vitiligo Treatment System has created a buzz on ... received from the persons who have tried it. Its principles ... interviewed some of the people who tried it and managed ...
(Date:5/20/2013)... Mombo from Comfort & Harmony was featured ... Consultant Association (USLCA) May 2nd – 5th. The conference ... professionals. , The USLCA annual conference is a ... learn about the latest trends in lactation. , ... which new mothers use to help support infants while ...
Breaking Medicine News(10 mins):Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3Health News:Review of Health Bill Impact in 2014 2Health News:Review of Health Bill Impact in 2014 3Health News:Fountain Valley, Ca Gum Disease Patients with Missing Teeth Can Now Receive Laser Gum Surgery from Dr. Robert Mokbel for Success with Dental Implants 2Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2
... men born with a severe urological anomaly in which ... more robust sexual lives than women born with the ... urologists at the Johns Hopkins Childrens Center. The condition, ... surgeries throughout infancy and childhood and into early adolescence.The ...
... MedImmune, Inc. today announced it will present three ... National Conference & Exhibition, adding to the companys growing ... virus (RSV), a leading cause of hospitalization among infants. ... provide key insights into how we can optimize the ...
... An osteoporosis management program keeps patients, doctors connected, ... -- Older patients with fractures benefit from a ... records and outreach programs, U.S. researchers say. , ... -- affects about 20 percent of women 65 ...
... DETROIT, Oct. 27 The American Red Cross,Blood Services ... United States into southern California to help stabilize the ... The American Red Cross has provided nearly 2,000 blood ... Southern California Blood Services Region.,Blood drives in southern California ...
... Company to provide up to $150,000 to relief agencies for recovery and ... ... Company,(NYSE: LLY ) today announced that it is responding to the ... for,the recovery and rebuilding efforts. "Our hearts go out to everyone ...
... and Operating Income plus Depreciation and Amortization ... Increased 2.96% and 4.71%, Respectively, ... ("Saba","GCS", "the Company" or "the Group"), one of the ... and,consumer goods, general merchandise, publications and other products,announced today ...
Cached Medicine News:Health News:MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics 2Health News:Older Women Gain From Good Post-Fracture Care 2Health News:American Red Cross Blood Services Supports Blood Needs of Southern California 2Health News:Eli Lilly and Company Aids California Recovery Effort 2Health News:Grupo Casa Saba Announces Third Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Third Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Third Quarter 2007 Results 4
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTC/1Q chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... ergonomic chairs with concave seats ... support • Select options like ... and glides. • BTT/1P chairs ... environments: industry, education, laboratory, clean ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With tubular ...
Medicine Products: